Skip to main content

Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed

Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee

Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HI

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HI

Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease

Pediatric Open-Label Extension Study

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Pediatric Open-Label Extension Study

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 146
  • Page 147
  • Page 148
  • Page 149
  • Page 150
  • Page 151
  • Page 152
  • Page 153
  • Page 154
  • …
  • Next page Next
  • Last page Last
Subscribe to